EU tells Hungary its &#x27sovereignty&#x27 law violates EU regulation

EU tells Hungary its &#x27sovereignty&#x27 law violates EU regulation


Hungarian Prime Minister Viktor Orban holds an annual intercontinental media briefing in Budapest, Hungary, December 21, 2023. 

Marton Monus | Reuters

Hungary’s new law on “safeguarding national sovereignty”, which the ruling Fidesz get together reported was important to shield against overseas political interference, violates European Union legislation, the European Fee reported on Wednesday.

The Commission claimed it had sent Hungary a formal discover that it would open an infringement process about the regulation, passed in December, which it claimed violated the union’s democratic values and elementary rights.

The Hungarian laws violates EU rules on democracy and the equal rights of EU citizens, the knowledge protection regulation and various regulations relevant to the inner current market, the Fee explained.

“The setup of a new authority with extensive-ranging powers and a strict regimeof monitoring, enforcement and sanctioning also threats to seriously hurt the democracy,” a Fee spokesperson reported.

The legislation came as nationalist Prime Minister Viktor Orban, who has clashed repeatedly with the European Union over democratic legal rights in Hungary, stepped up his party’s marketing campaign ahead of European Parliament elections up coming June.

Under the law, a different authority to explore and watch dangers of political interference will be established up. It will punish banned overseas financing for events or teams running for election with up to three a long time in jail.

Hungary has two months to reply to the letter of formal detect. If it does not handle the grievances stated in the letter, the Fee might come to a decision to ship a reasoned opinion – a official request to comply with EU legislation – as a up coming action in the process.



Source

Investors usually ‘sell in May and go away.’ Why that may not work this year
World

Investors usually ‘sell in May and go away.’ Why that may not work this year

“Sell in May and go away?” Some market participants say it could be better to wait and see this year. The old stock market adage speaks to the phenomenon in which the May-through-October stretch has seasonally borne out to be the worst six-month period of returns for stocks. With traders leaving their desks during the […]

Read More
Jury selection kicks off in Musk v. Altman trial
World

Jury selection kicks off in Musk v. Altman trial

A combination image shows Sam Altman, CEO of OpenAI, during the Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S., on November 16, 2023 and Elon Musk, Chief Executive Officer of SpaceX and Tesla and owner of X, formerly known as Twitter during Viva Technology conference dedicated to innovation and startups at the […]

Read More
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
World

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a) […]

Read More